CanniMed Therapeutics' IPO

CanniMed Therapeutics raised a round of funding on December 21, 2016. Investors include Public.

CanniMed Therapeutics is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry, with 15 years of pharmaceutical cannabis cultivation ex…

Articles about CanniMed Therapeutics' IPO: